JPH10245391A5 - - Google Patents
Info
- Publication number
- JPH10245391A5 JPH10245391A5 JP1997047963A JP4796397A JPH10245391A5 JP H10245391 A5 JPH10245391 A5 JP H10245391A5 JP 1997047963 A JP1997047963 A JP 1997047963A JP 4796397 A JP4796397 A JP 4796397A JP H10245391 A5 JPH10245391 A5 JP H10245391A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- acceptable salt
- active ingredient
- physiologically acceptable
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9047963A JPH10245391A (ja) | 1997-03-03 | 1997-03-03 | ７−グリコシロキシベンゾピラン誘導体を有効成分とする糖尿病治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9047963A JPH10245391A (ja) | 1997-03-03 | 1997-03-03 | ７−グリコシロキシベンゾピラン誘導体を有効成分とする糖尿病治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10245391A JPH10245391A (ja) | 1998-09-14 |
| JPH10245391A5 true JPH10245391A5 (cg-RX-API-DMAC10.html) | 2004-12-02 |
Family
ID=12790005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9047963A Pending JPH10245391A (ja) | 1997-03-03 | 1997-03-03 | ７−グリコシロキシベンゾピラン誘導体を有効成分とする糖尿病治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10245391A (cg-RX-API-DMAC10.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| US6683056B2 (en) | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
| US6555519B2 (en) | 2000-03-30 | 2003-04-29 | Bristol-Myers Squibb Company | O-glucosylated benzamide SGLT2 inhibitors and method |
| US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| US6670391B2 (en) | 2001-06-28 | 2003-12-30 | Dainippon Ink And Chemicals, Inc. | Benzopyran derivative and antiallergic agent |
| TW200504021A (en) | 2003-01-24 | 2005-02-01 | Bristol Myers Squibb Co | Substituted anilide ligands for the thyroid receptor |
| BRPI0913129A2 (pt) | 2008-05-22 | 2016-01-05 | Bristol Myers Squibb Co | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo |
| US9545610B2 (en) | 2013-03-04 | 2017-01-17 | Nova Chemicals (International) S.A. | Complex comprising oxidative dehydrogenation unit |
| CN104945455B (zh) * | 2014-03-28 | 2019-01-01 | 中国医学科学院药物研究所 | 香豆素苷类化合物、其制法和药物组合物与用途 |
| CN104861020B (zh) * | 2015-06-14 | 2017-05-17 | 海南医学院 | 一个苯丙素苷类化合物、其提取方法及其应用 |
| US11826376B2 (en) | 2018-07-19 | 2023-11-28 | Astrazeneca Ab | Methods of treating heart failure with preserved ejection fraction employing dapagliflozin and compositions comprising the same |
| US12409186B2 (en) | 2020-07-27 | 2025-09-09 | Astrazeneca Ab | Methods of treating chronic kidney disease with dapagliflozin |
| LT4188389T (lt) | 2020-07-27 | 2025-11-10 | Dapagliflozinas, skirtas panaudoti taikant lėtinės inkstų ligos gydymo būdą | |
| AU2022251165A1 (en) | 2021-04-01 | 2023-11-09 | Astrazeneca Uk Limited | Systems and methods for managing prediabetes with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition |
| WO2025125513A1 (en) | 2023-12-15 | 2025-06-19 | AstraZeneca Ireland Limited | Sglt2 inhibitors and baxdrostat for treating chronic kidney disease and hypertension |
-
1997
- 1997-03-03 JP JP9047963A patent/JPH10245391A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10245391A5 (cg-RX-API-DMAC10.html) | ||
| CA2136999A1 (en) | Peripheral vasodilating agent containing piperidine derivative as active ingredient | |
| CA2382480A1 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
| CA2341568A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
| IL112515A (en) | Pharmaceutical composition containing N,N-dimethyl-1-¬1-(4-chlorophenyl)cyclobutyl¾-3-methylbutylamine for use in the treatment of non-insulin dependent diabetes mellitus | |
| CA2102591A1 (en) | Hypoglycemic Agent | |
| CA2257016A1 (en) | Imidazolidin-4-one derivatives useful as anticancer agents | |
| KR930703303A (ko) | 1, 4-벤조티아제핀 유도체 | |
| KR890005124A (ko) | 세펨 화합물 및 이의 제조방법 | |
| JP2002519425A5 (cg-RX-API-DMAC10.html) | ||
| CA2190993A1 (en) | Protective agent for organ or tissue | |
| RU2003134629A (ru) | Соединения цефема | |
| CA2365359A1 (en) | Medicaments containing a sulfopyranosylglycerol derivative | |
| TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
| JP2000169325A5 (cg-RX-API-DMAC10.html) | ||
| KR960706472A (ko) | 프로스타글란딘 유도체, 그의 염 및 그의 사용 | |
| CA2317673A1 (en) | Novel allylthiopyridazine derivatives and process for preparing the same | |
| CA2373484A1 (en) | Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs | |
| IT1254280B (it) | Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson | |
| RU97112927A (ru) | Новое аминоолигосахаридное производное и способ его получения | |
| CA2195031A1 (en) | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | |
| CA2438506A1 (en) | Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications | |
| KR970064604A (ko) | 벤조피란 유도체 및 그의 심장질환 치료제로서의 용도 | |
| CA2222467A1 (fr) | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |